The choice depends on whether direct delivery (NAD+) or efficient oral absorption (NMN/NR) is more important for the specific research question
It's actually a clearing out
Researchers studying combined-compound protocols often investigate GHK-Cu, BPC-157, TB-500, and KPV together because the four compounds engage distinct molecular pathways that do not compete at the receptor or signalling-pathway level
- Glycerol used in the freezing medium was stored in light (if applicable): If stored in light, glycerol gets converted into acrolein, which is toxic to cells
We then performed labeling with BP probe
The usual mechanistic explanation is that the GHRH arm drives somatotroph cAMP signalling while the GHRP arm additionally attenuates somatostatin tone, so the two are acting on different limbs of the same axis rather than competing for one receptor